Mary Morgan

1.7k total citations
32 papers, 1.1k citations indexed

About

Mary Morgan is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Hematology. According to data from OpenAlex, Mary Morgan has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in Mary Morgan's work include Asthma and respiratory diseases (5 papers), Cystic Fibrosis Research Advances (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Mary Morgan is often cited by papers focused on Asthma and respiratory diseases (5 papers), Cystic Fibrosis Research Advances (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Mary Morgan collaborates with scholars based in United States, United Kingdom and Germany. Mary Morgan's co-authors include Ewa Kościelniak, Thomas Klingebiel, Philip Darbyshire, D. Harms, M. Herbst, Bernhard Schmidt, Günter Henze, Anthony V. Moorman, Ashish Masurekar and Helmut Gadner and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Mary Morgan

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Morgan United States 16 332 234 206 195 171 32 1.1k
Elizabeth C. Lorenz United States 25 433 1.3× 229 1.0× 125 0.6× 75 0.4× 279 1.6× 57 1.4k
Biswajit Dubashi India 15 115 0.3× 176 0.8× 210 1.0× 268 1.4× 98 0.6× 131 883
George M. Nassar United States 19 568 1.7× 84 0.4× 218 1.1× 61 0.3× 323 1.9× 48 1.6k
Ulas D. Bayraktar United States 18 122 0.4× 125 0.5× 407 2.0× 282 1.4× 141 0.8× 44 1.1k
Naohiko Fujii Japan 21 306 0.9× 54 0.2× 119 0.6× 108 0.6× 232 1.4× 68 1.7k
Elaine S. Kamil United States 17 181 0.5× 186 0.8× 94 0.5× 39 0.2× 280 1.6× 41 1.2k
David L. Nicol Australia 17 462 1.4× 300 1.3× 85 0.4× 314 1.6× 592 3.5× 32 1.7k
F. Leonard Johnson United States 15 322 1.0× 142 0.6× 392 1.9× 138 0.7× 88 0.5× 27 1.3k
Bernard L. Marini United States 18 92 0.3× 187 0.8× 186 0.9× 230 1.2× 88 0.5× 89 914
Polly E. Kintzel United States 14 172 0.5× 112 0.5× 67 0.3× 247 1.3× 85 0.5× 28 890

Countries citing papers authored by Mary Morgan

Since Specialization
Citations

This map shows the geographic impact of Mary Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Morgan more than expected).

Fields of papers citing papers by Mary Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Morgan. The network helps show where Mary Morgan may publish in the future.

Co-authorship network of co-authors of Mary Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Morgan. A scholar is included among the top collaborators of Mary Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Morgan. Mary Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Mary, et al.. (2019). Pulmonary Function Testing and Cardiopulmonary Exercise Testing. Medical Clinics of North America. 103(3). 565–576. 8 indexed citations
2.
Pengelly, Reuben J., Yifang Gao, Mary Morgan, et al.. (2016). Precision Molecular Diagnosis Defines Specific Therapy in Combined Immunodeficiency with Megaloblastic Anemia Secondary to MTHFD1 Deficiency. The Journal of Allergy and Clinical Immunology In Practice. 4(6). 1160–1166.e10. 12 indexed citations
3.
Insel, Michael, Mary Morgan, Michael S. Gough, et al.. (2016). Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study. Critical Care. 20(1). 335–335. 25 indexed citations
4.
Wheatley, Courtney M., Sarah E. Baker, Mary Morgan, et al.. (2015). Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis. Respiratory Medicine. 109(8). 1001–1011. 13 indexed citations
5.
Johnson, Elizabeth M., et al.. (2014). Lobar Collapse and Obliteration of Air Bronchogram Allowing Early Diagnosis of EndobronchialAspergillusInfection following Hematopoietic Stem Cell Transplantation. SHILAP Revista de lepidopterología. 2014. 1–4. 1 indexed citations
6.
Wheatley, Courtney M., Sarah E. Baker, Mary Morgan, et al.. (2014). Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis. Respiratory Medicine. 109(4). 463–474. 12 indexed citations
7.
Morgan, Mary, Michael S. Gough, Michael J. Apostolakos, et al.. (2012). Brachial artery reactivity in patients with severe sepsis: an observational study. Critical Care. 16(2). R38–R38. 21 indexed citations
8.
Baker, Sarah E., Eric C. Wong, Courtney M. Wheatley, et al.. (2012). Genetic Variation of SCNN1A Influences Lung Diffusing Capacity in Cystic Fibrosis. Medicine & Science in Sports & Exercise. 44(12). 2315–2321. 7 indexed citations
9.
Wiskin, Anthony E., et al.. (2012). Ten‐year experience of home parenteral nutrition in a single centre. Acta Paediatrica. 101(5). 524–527. 17 indexed citations
10.
Scheckenbach, Kathrin, Mary Morgan, Wolfram Scheurlen, et al.. (2011). Treatment of the bone marrow failure in Fanconi anemia patients with danazol. Blood Cells Molecules and Diseases. 48(2). 128–131. 40 indexed citations
11.
Chalmers, Elizabeth, P. Cooper, K. Forman, et al.. (2011). Purpura fulminans: recognition, diagnosis and management. Archives of Disease in Childhood. 96(11). 1066–1071. 126 indexed citations
12.
Gough, Michael S., Mary Morgan, Lauren M. Frasier, et al.. (2011). The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis*. Critical Care Medicine. 39(6). 1351–1358. 39 indexed citations
13.
Parker, Catriona, Rachel Waters, Jeremy Hancock, et al.. (2010). Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. The Lancet. 376(9757). 2009–2017. 229 indexed citations
14.
Morgan, Mary, Lauren M. Frasier, Judith C. Stewart, et al.. (2010). Artery-to-vein differences in nitric oxide metabolites are diminished in sepsis*. Critical Care Medicine. 38(4). 1069–1077. 19 indexed citations
15.
Hothi, Daljit K., Paul Bass, Mary Morgan, et al.. (2006). Acute renal failure in a patient with paroxysmal cold hemoglobinuria. Pediatric Nephrology. 22(4). 593–596. 13 indexed citations
16.
Kościelniak, Ewa, et al.. (2002). Soft Tissue Sarcoma in Children. Pediatric Drugs. 4(1). 21–28. 69 indexed citations
17.
Kościelniak, Ewa, D. Harms, Günter Henze, et al.. (1999). Results of Treatment for Soft Tissue Sarcoma in Childhood and Adolescence: A Final Report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. Journal of Clinical Oncology. 17(12). 3706–3719. 200 indexed citations
18.
Treuner, J. & Mary Morgan. (1995). Clinical Management of Soft Tissue Sarcomas. Current topics in pathology. 89. 17–30. 2 indexed citations
19.
Lewis, Ian, et al.. (1992). Prognostic factors in juvenile chronic granulocytic leukaemia.. PubMed. 18. S68–71. 6 indexed citations
20.
Morgan, Mary, et al.. (1957). 2H-Pyran-3,5(4H,6H)-Diones. Journal of the American Chemical Society. 79(2). 422–424. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth C. Lorenz Breakdown of academic impact, for papers by Biswajit Dubashi Breakdown of academic impact, for papers by George M. Nassar Breakdown of academic impact, for papers by Ulas D. Bayraktar Breakdown of academic impact, for papers by Naohiko Fujii Breakdown of academic impact, for papers by Elaine S. Kamil Breakdown of academic impact, for papers by David L. Nicol Breakdown of academic impact, for papers by F. Leonard Johnson Breakdown of academic impact, for papers by Bernard L. Marini Breakdown of academic impact, for papers by Polly E. Kintzel
Rankless by CCL
2026